Yu, Qiuning
Xia, Namei
Zhao, Yanteng
Jin, Huifang
Chen, Renyin
Ye, Fanglei
Chen, Liyinghui
Xie, Ying
Wan, Kangkang
Zhou, Jun
Zhou, Dihan
Lv, Xianping
Funding for this research was provided by:
Medical Science and Technology Research Plan Joint Construction Project of Henan Province (2018020121)
Article History
Received: 16 May 2022
Accepted: 22 November 2022
First Online: 29 November 2022
Declarations
:
: Approval for this study was obtained from the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Approval Number 2020-KY-0152). All experiments were performed in accordance with relevant guidelines and regulations. Written informed consent was obtained from individual or guardian participants.
: Not applicable.
: Wuhan Ammunition Life-tech Company, Ltd. has applied for the patent relating to <i>HOXD1</i> and <i>HOXC10</i>. The other authors declare no conflict of interest.